1-3 of 3
Tadeusz Robak, Prof
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL

Open Access
Clinical Trials & Observations
Jan A. Burger, Paul M. Barr, Tadeusz Robak, Prof., Carolyn Owen, Alessandra Tedeschi, Anita Sarma, Piers EM Patten, Sebastian Grosicki, Helen McCarthy, Dr, Fritz Offner, Edith Szafer Glusman, Cathy Zhou, Anita Szoke, Lynne Neumayr, James P. Dean, Paolo Ghia, Thomas Kipps
Journal: Blood
Blood blood.2024028205.
https://doi.org/10.1182/blood.2024028205
Published: 2025
Includes: Supplemental data
Journal Articles

Expression of Smad Proteins as a Potential Prognostic Factor in Chronic Lymphocytic Leukemia

Free
Magdalena Witkowska, MD, Barbara Cebula-Obrzut, PhD, Agata Majchrzak, PhD, Aleksandra Medra, PhD, Tadeusz Robak, Prof, Piotr Smolewski, Prof
Journal: Blood
Blood (2014) 124 (21): 1957.
https://doi.org/10.1182/blood.V124.21.1957.1957
Published: 2014
Journal Articles

Nanoparticles – a Novel Approach to Chronic Lymphocytic Leukemia Treatment?

Free
Ida Franiak-Pietryga, PhD, Ewelina Ziolkowska, MSc, Barbara Ziemba, PhD, Dietmar Appelhans, PhD, Brigitte Voit, Prof., Joanna Gora-Tybor, Prof., Tadeusz Robak, Prof., Barbara Klajnert, Prof., Maria Bryszewska, Prof.
Journal: Blood
Blood (2012) 120 (21): 4601.
https://doi.org/10.1182/blood.V120.21.4601.4601
Published: 2012